Open research questions in Inflammatory Bowel Disease
353 unresolved questions extracted from the limitations and future-work sections of 935 Inflammatory Bowel Disease papers in our library. Each links back to the study that raised it.
What the literature leaves open
Lack of dedicated clinical trials assessing the efficacy of available therapies for perianal fistulizing Crohn’s disease. Limited understanding of the etiology of perianal fistulizing Crohn's disease. Sub-optimal management of perianal fistulizing Crohn's disease.
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease · 2026 · DOIfurther studies are needed to investigate the association between breastfeeding and UC risk, - more research is needed to explore the relationship between dietary patterns and UC risk, - studies should investigate the effects of different types of antibiotic exposure on UC risk
Dietary, lifestyle, and environmental factors associated with ulcerative colitis: a systematic review and meta-analysis of observational studies · 2026 · DOIThe specific associations between dietary, lifestyle, and environmental exposures and the risk of incident ulcerative colitis are not well understood. Prior studies have reported inconsistent findings, and a comprehensive systematic review and meta-analysis is needed to clarify the relationships between these factors and ulcerative colitis risk.
Dietary, lifestyle, and environmental factors associated with ulcerative colitis: a systematic review and meta-analysis of observational studies · 2026 · DOIthe evidence is limited by heterogeneity, small sample sizes, retrospective designs, and lack of standardized outcome measures, - there are no validated Behcȩt-specific IFX or ADA trough targets, - guideline recommendations remain divergent
Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring · 2026 · DOIfurther studies are needed to validate Behcȩt-specific therapeutic trough targets for infliximab and adalimumab, - research on proactive TDM is evolving
Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring · 2026 · DOIOne challenge is the large, noisy, and modality-specific nature of spatial data, requiring computational methods to assign cell types and detect spatial statistics. Another challenge is the need for standard data structures and benchmarking efforts to make spatial data analysis pipelines comparable across studies. The paper also highlights the challenge of demonstrating reproducible incremental value of spatial biomarkers beyond established clinical, serum, stool, endoscopic, histological, and imaging variables.
Spatial multi-omics-guided drug development in inflammatory bowel disease: from mucosal immune niches to precision therapy · 2026 · DOIProgression from an exploratory tissue signature to a clinically actionable biomarker will require an assay-locked platform, prespecified thresholds, and prospective external validation
Spatial multi-omics-guided drug development in inflammatory bowel disease: from mucosal immune niches to precision therapy · 2026 · DOIFurther exploration of the structural dynamics underlying international research cooperation, - Investigation of the shift in research emphasis toward precision medicine and predictive modeling
Biologic therapy for Crohn’s disease (2015–2025): a bibliometric analysis of global research trends and current status · 2026 · DOIThe lack of systematic tracking of research trends on biologic therapy for Crohn's disease. The need for a comprehensive bibliometric analysis to map the research landscape of biologic therapy for Crohn's disease.
Biologic therapy for Crohn’s disease (2015–2025): a bibliometric analysis of global research trends and current status · 2026 · DOIInvestigate the effects of different types of physical activity on UC risk, - Examine the relationship between physical activity and UC risk in different age groups or populations, - Develop and test UC prevention guidelines based on accelerometer-based measurements
Accelerometer-measured physical activity and risk of incident ulcerative colitis: a population-based prospective study · 2026 · DOIThe absence of established preventive strategies for ulcerative colitis. The inconsistent results of prior studies on the physical activity-ulcerative colitis risk relationship.
Accelerometer-measured physical activity and risk of incident ulcerative colitis: a population-based prospective study · 2026 · DOIThe mechanisms influencing self-management behaviors in adolescents and young adults with IBD remain under-explored. Prior work has not fully examined the chain mediating role of basic psychological needs and anxiety/depression in the relationship between perceived social support and self-management behaviors.
The association between perceived social support and self-management behaviors in adolescents and young adults with inflammatory bowel disease: the chain mediating role of basic psychological needs and anxiety/depression · 2025 · DOIcurrent research supports that IBD remains incompletely understood, - physiological changes associated with IBD lead to inconsistent drug release, - highly variable transit time makes it difficult to control time-released drug delivery
Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery · 2025 · DOIfurther research is needed to pair NET inhibition with ROS-responsive nanocarriers, - new avenues are emerging for UC and CD treatment, including new monoclonal antibody therapies
Advancing Inflammatory Bowel Disease Treatment by Targeting the Innate Immune System and Precision Drug Delivery · 2025 · DOIa thyroid function monitoring - exploring the genetic and immunologic connections between IBD and thyroid disorders - further research to enhance our understanding of the interrelation between IBD and thyroid disorders
Thyroid disorders and inflammatory bowel disease: an association present in adults but also in children and adolescents · 2025 · DOIMalnutrition in IBD patients results from various complex factors such as inflammatory response and clinical complications. The lack of standardized evaluation tools available for patients with IBD. The need to identify malnutrition in IBD patients to impact their prognosis.
The simplified GLIM criteria for assessment of malnutrition and its correlation with clinical outcomes in Crohn’s disease patients · 2025 · DOIthe study was conducted at a single hospital, - the study had a limited sample size of 386 patients, - the study was retrospective, - the loss of muscle mass was not analyzed due to the absence of data collected in the original database
The simplified GLIM criteria for assessment of malnutrition and its correlation with clinical outcomes in Crohn’s disease patients · 2025 · DOIdevelopment of a more personalized approach to avoid unnecessary treatments and toxicities - investigation of the role of gut microbiota in determining therapeutic failure
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease · 2024 · DOIConduct of pragmatic clinical trials using the established priors, - Further research on the biology underlying perianal fistulizing Crohn's disease
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease · 2026 · DOIBackground and AimsFibrostenotic stricture is a severe complication of Crohns disease (CD) that affect up to 50% of patients over their lifetime, causing irreversible narrowing of the intestinal lumen and bowel obstruction, but the molecular programs that distinguish stenotic from non-stenotic inflammation and the relative contributions of fibrosis and smooth-muscle remodeling remain incompletely characterized.
Layer-Resolved Spatial Transcriptomic Profiling Reveals Distinct Fibrotic and Muscularizing Submucosal Niches in Fibrostenotic Crohn's Disease · 2026 · DOIAbstract Background Adipose tissue measures are poorly defined in pediatric Crohn’s disease (CD).
Conclusion Available evidence does not suggest increased risks of incident or recurrent cancers with IM therapies in individuals with IBD after cancer, although data are limited.
Post-cancer use of immune-modulating therapies in individuals with inflammatory bowel disease: a review of risks and recommendations · 2026 · DOIHowever, data on the association of the ITGA4 rs1143674 variant with subclinical atherosclerosis in UC patients are lacking in the literature, and the impact of age on the manifestation of this genetic risk has not been evaluated.
Association of the ITGA4 rs1143674 polymorphism with subclinical atherosclerosis in patients with ulcerative colitis over 40 years of age · 2026 · DOIConclusions These observations support an alternative view of CD in which intestinal lymphatic dysfunction plays an under-recognized role in both promoting and sustaining inflammation.
Conclusions Disability literature in PIBD is scarce and lacks a pediatric‐specific instrument.
Disability in pediatric inflammatory bowel diseases: A systematic review and a single center experience · 2026 · DOI
Most-cited papers in Inflammatory Bowel Disease
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies · The Lancet · 2017 · 5,572 citations
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease · Nature · 2001 · 4,417 citations
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease · Nature · 2012 · 4,325 citations
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease · Nature · 2001 · 3,944 citations
- Unravelling the pathogenesis of inflammatory bowel disease · Nature · 2007 · 3,722 citations
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial · The Lancet · 2002 · 3,461 citations
- Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis · New England Journal of Medicine · 2005 · 3,329 citations
- Inflammatory Bowel Disease · New England Journal of Medicine · 2002 · 2,956 citations
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease · New England Journal of Medicine · 2010 · 2,722 citations
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease · New England Journal of Medicine · 1997 · 2,579 citations
Most recent work
- Perianal Disease in Pediatric-Onset Crohn’s Disease: Incidence, Disease Course, and Long-Term Outcomes · Clinical Gastroenterology and Hepatology · 2026
- Plant‐Based Food Preferences Rich in Polyphenols and Their Causal Effects on Inflammatory Bowel Disease · Food Science & Nutrition · 2026
- Multiome-seq links inflammatory bowel disease polygenic risk to TNF inhibitor response · bioRxiv · 2026
- Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis · Alimentary Pharmacology & Therapeutics · 2026
- Diagnostic Performance of Individual CT Signs for Identifying Ischemia and Necrosis in Small Bowel Obstruction: A Systematic Review and Meta-Analysis · American Journal of Roentgenology · 2026
- Mirikizumab Long-Term Efficacy and Safety in Patients With Crohn’s Disease: Results From the VIVID-2 Open-Label Extension Trial · Clinical Gastroenterology and Hepatology · 2026
- Management of Crohn Disease in Adults · JAMA · 2026
- Current and emerging approaches to manage chronic inflammatory gut disorders · Frontiers in Cellular and Infection Microbiology · 2026
- Robotic ileal pouch-anal anastomosis after proctectomy: a feasible and promising approach? Short-term outcomes and long-term functional results from a two-center retrospective study · Journal of Robotic Surgery · 2026
- Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation · Frontiers in Cell and Developmental Biology · 2026
Find a gap in your own Inflammatory Bowel Disease sub-topic
This page shows what the Inflammatory Bowel Disease literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →